These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2825063)

  • 1. [3H]cyclofoxy, a ligand suitable for positron emission tomography, labels mu and kappa opioid receptors.
    McLean S; Rice KC; Lessor R; Rothman RB
    Neuropeptides; 1987 Oct; 10(3):235-9. PubMed ID: 2825063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An examination of the opiate receptor subtypes labeled by [3H]cycloFOXY: an opiate antagonist suitable for positron emission tomography.
    Rothman RB; McLean S
    Biol Psychiatry; 1988 Mar; 23(5):435-58. PubMed ID: 2894229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A brief study of the selectivity of norbinaltorphimine, (-)-cyclofoxy, and (+)-cyclofoxy among opioid receptor subtypes in vitro.
    Rothman RB; Bykov V; Reid A; De Costa BR; Newman AH; Jacobson AE; Rice KC
    Neuropeptides; 1988 Oct; 12(3):181-7. PubMed ID: 2853839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of [3H]cyclofoxy retention in rat brain after in vivo injection corresponds to the in vitro opiate receptor distribution.
    Ostrowski NL; Burke TR; Rice KC; Pert A; Pert CB
    Brain Res; 1987 Feb; 402(2):275-86. PubMed ID: 3030494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography.
    Rothman RB; McLean S; Bykov V; Lessor RA; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1987 Oct; 142(1):73-81. PubMed ID: 2826178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramine.
    Benkelfat C; Aulakh CS; Bykov V; Rice KC; De Costa BR; Rothman RB
    J Pharm Pharmacol; 1989 Dec; 41(12):865-7. PubMed ID: 2576452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in guinea pig brain.
    Sim LJ; Childers SR
    J Comp Neurol; 1997 Oct; 386(4):562-72. PubMed ID: 9378852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.
    Kling MA; Carson RE; Borg L; Zametkin A; Matochik JA; Schluger J; Herscovitch P; Rice KC; Ho A; Eckelman WC; Kreek MJ
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1070-6. PubMed ID: 11082442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic visualization of kappa opioid receptors with labelled dynorphins in guinea pig brain.
    Slater P; Cross AJ; Hewitt L; Savage WJ
    J Recept Res; 1989; 9(2):171-80. PubMed ID: 2568485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors.
    Sharif NA; Hughes J
    Peptides; 1989; 10(3):499-522. PubMed ID: 2550910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution.
    Liu-Chen LY; Li SX; Lewis ME
    Brain Res; 1991 Mar; 544(2):235-42. PubMed ID: 1645609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain.
    Rothman RB; Bykov V; de Costa BR; Jacobson AE; Rice KC; Brady LS
    Peptides; 1990; 11(2):311-31. PubMed ID: 2162533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]dynorphin A binding and kappa selectivity of prodynorphin peptides in rat, guinea-pig and monkey brain.
    Young EA; Walker JM; Lewis ME; Houghten RA; Woods JH; Akil H
    Eur J Pharmacol; 1986 Mar; 121(3):355-65. PubMed ID: 2870933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A photoactivatable naltrexone derivative labels glycoproteins of different molecular weight corresponding to the mu- and kappa-opioid receptors.
    Mejean A; Hawkinson J; Guthapfel R; Goeldner M; Hirth C
    Biochemistry; 1992 Oct; 31(40):9685-93. PubMed ID: 1327126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies.
    Sawada Y; Kawai R; McManaway M; Otsuki H; Rice KC; Patlak CS; Blasberg RG
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):183-203. PubMed ID: 1847702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of the heterogeneity of the kappa-opioid receptors in guinea-pig cerebellum using selective and nonselective drugs.
    Tiberi M; Magnan J
    Eur J Pharmacol; 1990 Jun; 188(6):379-89. PubMed ID: 2164939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.